Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs STMicroelectronics NV (STM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs STMicroelectronics NV — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while STMicroelectronics NV trades at $45.07 (market cap $43.80B). The key difference: STMicroelectronics NV is far larger — about 8.5× Oruka Therapeutics Inc. Common Stock's market cap, and STMicroelectronics NV pays a 0.73% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and STMicroelectronics NV for 65 Days on average.
| ORKA | STM | |
|---|---|---|
Market Cap | $5.18B | $43.80B |
Volume | 490,798 | 7,353,071 |
Sector | Health | Technology |
52-Week High | $113.08 | $79.91 |
52-Week Low | $26.19 | $21.20 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $4.31B | $41.32B |
Dividend Yield | — | 0.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
STM is trading at $46.9, down 7.09% in the last session, with a bearish technical signal. The company shows mixed fundamentals with a high P/E ratio of 94.59 but negative net income margin of -0.39%. Recent Q2 2026 earnings beat expectations with EPS of $0.31 versus $0.26 expected, while Q1 and Q4 2025 missed. Strong cash flow of $555M in 2025 and improving 2026 projections provide some optimism amid current weakness.
The outlook remains cautious with analyst consensus price target of $77.31 suggesting 65% upside potential. Key opportunities include AI data-center revenue projected to exceed $2B in 2027 and automotive sensor innovations. Risks include declining revenue trends from $17.3B in 2023 to $11.8B in 2025 and negative profitability metrics requiring careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →
